$CURR News March 23, 2021 CURE Pharmaceutical Aug
Post# of 24925
CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline https://finance.yahoo.com/news/cure-pharmaceu...00116.html